Durable Clinical Responses and Long-Term Follow-Up of Stage III-IV Non-Small-Cell Lung Cancer (NSCLC) Patients Treated With IDO Peptide Vaccine in a Phase I Study-A Brief Research Report
about
Durable Clinical Responses and Long-Term Follow-Up of Stage III-IV Non-Small-Cell Lung Cancer (NSCLC) Patients Treated With IDO Peptide Vaccine in a Phase I Study-A Brief Research Report
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Durable Clinical Responses and ...... Study-A Brief Research Report
@en
Durable Clinical Responses and ...... -IV Non-Small-Cell Lung Cancer
@nl
type
label
Durable Clinical Responses and ...... Study-A Brief Research Report
@en
Durable Clinical Responses and ...... -IV Non-Small-Cell Lung Cancer
@nl
prefLabel
Durable Clinical Responses and ...... Study-A Brief Research Report
@en
Durable Clinical Responses and ...... -IV Non-Small-Cell Lung Cancer
@nl
P2093
P2860
P356
P1476
Durable Clinical Responses and ...... Study-A Brief Research Report
@en
P2093
Anders Mellemgaard
Julie Westerlin Kjeldsen
Lotte Engell-Noerregaard
Trine Zeeberg Iversen
P2860
P356
10.3389/FIMMU.2018.02145
P407
P577
2018-01-01T00:00:00Z